4 research outputs found

    The Economic Feasibility of Producing Pasture Poultry for Limited Resource Farmers in Southeastern North Carolina

    Get PDF
    This study examines the economic feasibility of two pasture poultry production operations (pasture pen and net range) by limited resource farmers (LRFs) using the Net Present Value (NPV) method of analysis. Results of the NPV method illustrated unacceptable investments for both production operations.Alternative Enterprises, Agricultural Prosperity, Pasture Poultry Production, Limited Resource Farming, Farm Management, Land Economics/Use,

    The Economic Feasibility of Producing Pasture Poultry for Limited Resource Farmers in Southeastern North Carolina

    Full text link
    This study examines the economic feasibility of two pasture poultry production operations (pasture pen and net range) by limited resource farmers (LRFs) using the Net Present Value (NPV) method of analysis. Results of the NPV method illustrated unacceptable investments for both production operations

    Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia

    Full text link
    Summary: Genetic S6K1 inactivation can induce apoptosis in PTEN-deficient cells. We analyzed the therapeutic potential of S6K1 inhibitors in PTEN-deficient T cell leukemia and glioblastoma. Results revealed that the S6K1 inhibitor LY-2779964 was relatively ineffective as a single agent, while S6K1-targeting AD80 induced cytotoxicity selectively in PTEN-deficient cells. In vivo, AD80 rescued 50% of mice transplanted with PTEN-deficient leukemia cells. Cells surviving LY-2779964 treatment exhibited inhibitor-induced S6K1 phosphorylation due to increased mTOR-S6K1 co-association, which primed the rapid recovery of S6K1 signaling. In contrast, AD80 avoided S6K1 phosphorylation and mTOR co-association, resulting in durable suppression of S6K1-induced signaling and protein synthesis. Kinome analysis revealed that AD80 coordinately inhibits S6K1 together with the TAM family tyrosine kinase AXL. TAM suppression by BMS-777607 or genetic knockdown potentiated cytotoxic responses to LY-2779964 in PTEN-deficient glioblastoma cells. These results reveal that combination targeting of S6K1 and TAMs is a potential strategy for treatment of PTEN-deficient malignancy. : Liu et al. find that the S6K1 inhibitor, AD80, is selectively cytotoxic for PTEN-deficient cancer cells, while LY-2779964 is ineffective as a single agent. AD80 avoids S6K1 priming and co-targets TAM tyrosine kinases. Combining LY-2779964 with the TAM kinase inhibitor BMS-777607 is selectively cytotoxic for PTEN-deficient cells. Keywords: S6K1, leukemia, LY-2779964, PF4708671, AD80, Pten, BMS-777607, AXL, TAM, glioblastom
    corecore